Fundraising Fox

Intezyne Technologies

Tampa, US · Delaware corporation

Biotech

Founders & leadership

KS
Kevin SillFounder
DD
Daniel DeversExecutive
CP
Carolyn ParadiseExecutive

Board

HS
Hooshmand SheshbaradaranBoard director
MC
Michael ColeBoard director
MF
Michael FountainBoard director
JM
John McBrideBoard director

Reported raises · per SEC filings

Form D private placements

$480K disclosed across 1 round · 2016

▶$480KraisedJun 2016 · 1 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Michael ColeDirector
  • Kevin SillExecutive Officer
  • Daniel DeversExecutive Officer
  • Carolyn ParadiseExecutive Officer
  • Michael FountainDirector
  • John McBrideDirector
  • Hooshmand SheshbaradaranDirector
Offering amount
$12M
Amount sold
$480K
First sale
May 2016
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Intezyne Closes Oversubscribed $10M Series A Financing to Drive Rapid Oncology Portfolio Developmentprnewswire.com · Oct 2017Intezyne Technologies LLC Initiates First-In-Human Trials For Topoisomerase-1 Inhibitor IT-141; GRP78 Inhibitor IT-139 To Be Featured In AACR Symposium - BioSpacebiospace.com · Mar 2017

Frequently asked questions

Who founded Intezyne Technologies?
Intezyne Technologies was founded by Kevin Sill.
How much funding has Intezyne Technologies raised?
Intezyne Technologies has disclosed $480K raised across 1 round.
Where is Intezyne Technologies headquartered?
Intezyne Technologies is headquartered in Tampa, US.